April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to provide protection against infections. The AigisRx Flat delivers the antimicrobial agents rifampin and minocycline. "The current AigisRx envelope provides potent antimicrobial protection and also anchors the device to prevent device migration. However, in patients who are undergoing battery change-outs, using the AigisRx Flat option helps minimize dissection of the pre-existing pocket,” said Heather Bloom, M.D., assistant professor of medicine, Emory University School of Medicine, director, cardiac electrophysiology services, Atlanta Veterans Affairs Medical Center. “Since the risk of infection is much higher in change-outs, partially due to the vascular pocket preventing tissue penetration by oral antibiotics, having a drug-eluting device on the site is of critical importance." Hospitalization for device infection increased faster than rates of device implants from 1996 through 2006, according to the National Hospital Discharge Survey, conducted by the Centers for Disease Control and Prevention. This was further reinforced in the January 2010 guideline issued by the American Heart Association and the Heart Rhythm Society, which explicitly states there is a significant unmet clinical need in device-related infection. Following commercial release in 2008, Aigisrx envelope has been implanted in more than 8,500 patients nationwide. For more information: www.TYRX.com
If you enjoy this content, please share it with a colleague
Wrap Helps Reduce Pacemaker, Defibrillator Infections
Related Content
February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...
January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...
September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...
August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...
Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...
October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...
Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage ...
May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...
May 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...